Stay updated on Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.

Latest updates to the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows revision v3.6.3, replacing v3.6.2, indicating a small update to the page without altering the displayed study details.SummaryDifference0.1%

- Check19 days agoChange DetectedNew page revision v3.6.2 has been applied, replacing the previous v3.6.0. This appears to be a maintenance update that does not modify the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check33 days agoChange DetectedThe page adds new navigation/help links (Check who can join, How to Join a Study, Find Contact Information, How to Read a Study Record, Common Questions) and standardizes the Intervention/Treatment label while updating the revision tag to v3.6.0.SummaryDifference0.5%

- Check41 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, indicating a new version of the page's documentation.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision indicator was updated from v3.5.3 to v3.5.4, indicating a newer build of the page. No user-facing content or study data were altered.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page shows Revision: v3.5.3, updating the prior revision tag from v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and SRS for Brain Metastases in Breast Cancer: Clinical Trial page.